Antiphospholipid antibodies (aPL) have been most strongly associated with a syndrome (APS) characterized by venous and/or arterial thrombosis, thrombocytopenia, recurrent fetal losses and a variety of non-thrombotic and thrombotic neurological disorders. Cerebral ischemia associated with aPL is the most common arterial thrombotic manifestation. Other neurological syndromes, such as cognitive dysfunction, dementia, psychosis, depression, seizures, chorea and transverse mielopathy, have all been associated with antiphospholipid antibodies.
Neurological involvement in antiphospholipid antibodies syndrome (APS) / Amoroso, Antonio; Mitterhofer, Anna Paola; Ferri, Giovanni Maria; M., Galluzzo; M., Vadacca; A., Afeltra. - In: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES. - ISSN 1128-3602. - 3:5(1999), pp. 205-209.
Neurological involvement in antiphospholipid antibodies syndrome (APS)
AMOROSO, Antonio;MITTERHOFER, Anna Paola;FERRI, Giovanni Maria;
1999
Abstract
Antiphospholipid antibodies (aPL) have been most strongly associated with a syndrome (APS) characterized by venous and/or arterial thrombosis, thrombocytopenia, recurrent fetal losses and a variety of non-thrombotic and thrombotic neurological disorders. Cerebral ischemia associated with aPL is the most common arterial thrombotic manifestation. Other neurological syndromes, such as cognitive dysfunction, dementia, psychosis, depression, seizures, chorea and transverse mielopathy, have all been associated with antiphospholipid antibodies.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
